Averna Therapeutics News and Activities

Acquisition, funding and merger involving Averna Therapeutics.

• Averna Therapeutics has just announced a $82 Million fundraising (posted on June 25 2024).

View the org chart displaying its 15 main executives

Most searched biographies at Averna Therapeutics

• Thomas Barnes, Chief Executive Officer
• Stephen Squinto, Director
• Henry Chen, Board Member

Popular executive movements at Averna Therapeutics

• Richard Morris has joined the company as Chief Financial Officer  (posted on March 30 2026).
• Robert Mabry has joined the company as Chief Scientific Officer  (posted on March 30 2026).

Create your alert
to follow the executive moves at Averna Therapeutics.

Averna Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Averna Therapeutics

Social media about Averna Therapeutics

• Averna Therapeutics on Wikipedia, Google News & Yahoo Finance
• Averna Therapeutics on LinkedIn, X (Twitter) & YouTube